MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase

MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient

April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we

Taking a new treatment from lab to patient is a long, highly regulated process that demands years of research, significant

MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments

Effective project management is vital to the success of a clinical trial, helping to ensure that studies are conducted smoothly,

At the end of 2024, MAC Laboratory Services reached an exciting milestone: full accreditation under the Good Laboratory Practice (GLP)

As we wrap up 2024, it’s the perfect time to look back at a year filled with exciting advancements, initiatives

MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human

At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences,

We are pleased to share a recent publication in conjunction with the UK Health Security Agency (UKHSA) and insights from

MAC Clinical Research’s Manchester site is an MHRA audited and accredited Phase I centre located within and supported by the

As well as working towards being a more sustainable company, there is a big drive for us to pass this

MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in a phase

MAC Clinical Research is pleased to announce that we have joined the United Nations Global Compact initiative — a voluntary

Clinical trials are a costly business, but with trial quality being so critical to patient safety and data integrity, getting

Join us on 20th May to celebrate Clinical Trials Day! A day when the clinical research industry comes together to

Dementia is a complex condition that causes a decline in cognitive abilities and interferes with daily life. It affects memory,

MAC Clinical Research (MAC) is proud to announce the acquisition of Intelligent Clinical, a clinical research site that specialises in

In a recent 12-month progress report, the UK Government announced that it recognises women’s health, and particularly menopause, as an

This week is Healthcare Science Week, an annual celebration of the many careers in healthcare science. Every year, this week

In comparison to their larger counterparts, smaller to midsize CROs can offer several advantages when it comes to conducting clinical

The UK’s independent Parliamentary Office of Science and Technology (POST) has issued a rapid response on psychedelic-assisted therapy for anxiety

A Contract Research Organisation (CRO) is a company contracted to provide day-to-day clinical research support to various organisations, such as

We are delighted to announce that MAC Clinical Research has received approval for the French Research Tax Credit (Crédit d’impôt

Race Equality Week (5-11 February) is an annual UK-wide movement that unites hundreds of thousands of organisations and individuals to

We are proud to announce that MAC Clinical Research has received a bronze medal from EcoVadis, the world’s most trusted

At MAC Clinical Research, we take our Corporate Social Responsibility (CSR) very seriously. Our commitment is multifaceted and extends throughout

As we come closer to the end of the year, I want to take the opportunity to reflect on 2023

At MAC, we consistently prioritise subject diversity in the trials we run and manage. We highly value this commitment and,

Did you know we provide an array of scientific solutions for our sponsors? One of these bespoke and highly interesting

To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has

MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to

As we approach the end of the year, it’s only natural to reflect on the previous 12 months, whether from

Keeping the patient at the heart of our research: My take-homes from speaking at the C3 Summit discussing inclusivity and

SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC to support a new

At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988.

The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and investment on

To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has

October 24, 2018 MANCHESTER, ENGLAND  Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient

MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).